Article: Hagens Berman Sobol Shapiro: Suit Filed Against Bristol-Myers Squibb Over Tequin.

Complaint alleges manufacturer failed to communicate the severe side effects of the popular drug

SEATTLE, July 31 /PRNewswire/ -- Hagens Berman Sobol Shapiro filed a lawsuit today against Bristol-Myers Squibb and Schering Corporation , claiming its antibiotic drug Tequin causes severe blood-sugar issues in some patients which could lead to debilitating long-term healthcare issues including diabetes, and death.

Tequin and its generic equivalent gatifloxacin was commonly prescribed for sinus, lung, and urinary tract infections, as well as other illnesses.

According to Rob Carey, lead attorney from HBSS, safety concerns regarding Tequin began to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!